Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: Pediatr Neurol. 2019 May 9;98:53–60. doi: 10.1016/j.pediatrneurol.2019.05.001

Early Detection of Cerebral Palsy Using Sensorimotor Tract Biomarkers in Very Preterm Infants

Nehal A Parikh 1,2,3,*, Alexa Hershey 3, Mekibib Altaye 2,4
PMCID: PMC6717543  NIHMSID: NIHMS1528889  PMID: 31201071

Abstract

Background:

Our objectives were to evaluate the brain’s sensorimotor network microstructure using diffusion magnetic resonance imaging (MRI) at term corrected age and test the ability of sensorimotor microstructural parameters to accurately predict cerebral palsy in extremely low birth weight infants.

Methods:

We enrolled a prospective pilot cohort of extremely low birth weight preterm infants (BW ≤1000g) before neonatal intensive care unit discharge and studied them with structural and diffusion MRI at term corrected age. Six sensorimotor tracts were segmented and microstructural parameters from these tracts were evaluated for their ability to predict later development of cerebral palsy, diagnosed at 18- to 22-months corrected age.

Results:

We found significant differences in multiple diffusion MRI parameters from 5 of the 6 sensorimotor tracts in infants that developed cerebral palsy (N=5) versus those that did not (N=36). As compared to structural MRI or individual diffusion MRI biomarkers, the combination of two individual biomarkers – fractional anisotropy of superior thalamic radiations (sensory component) and radial diffusivity of the corticospinal tract – exhibited the highest sensitivity (80%), specificity (97%) and positive likelihood ratio (28.0) for prediction of cerebral palsy. This combination of diffusion MRI biomarkers accurately classified 95% of the study infants.

Conclusions:

Development of cerebral palsy in very preterm infants is preceded by early brain injury and/or immaturity to one or more sensorimotor tracts. A larger study is warranted to evaluate if a combination of sensorimotor microstructural biomarkers could accurately facilitate early diagnosis of cerebral palsy.

Keywords: Magnetic resonance imaging; neuroimaging, diffusion magnetic resonance imaging, infant, premature, extremely low birth weight infant, cerebral palsy, motor disorders, cohort studies, prognosis

1. Introduction

Cerebral palsy (CP) is the most common physical disability in children and a life-long disorder that can worsen without treatment1,2. Infants born extremely preterm have a 50-fold higher risk of CP as compared with infants born at term2. In most clinical settings, the average age at diagnosis of CP is typically 2 years or beyond, despite the etiologic role brain injury and/or abnormal brain development play in development of CP3,4. This delay in diagnosis results in part because neuroimaging utilized in clinical decision-making appears normal in up to 30% of CP cases58. There is wide consensus that earlier diagnosis, soon after birth, is urgently needed to take full advantage of critical windows of early brain development9,10. Earlier diagnosis would facilitate targeted delivery of early childhood interventions1113 and novel habilitative therapies during this optimal period9,14. Unfortunately, currently used tests for early detection of CP such as qualitative structural MRI (sMRI) or general movements assessment (GMA) are not sufficient on their own and it is unknown if combining them improves prediction accuracy sufficiently to permit individual level predictions1517.

There is mounting evidence that advanced modes of MRI such as diffusion MRI (dMRI), brain morphometry, and magnetic resonance spectroscopy biomarkers can predict CP in very preterm infants18. As compared to sMRI, these advanced modes are quantitative, more sensitive and more objective at detecting injury. In addition to the brain’s macrostructure, they can query its microstructure and metabolites. Diffusion MRI exploits and is sensitive to the ubiquitous presence of water molecules in the brain’s microarchitecture by measuring its diffusion properties. Water moves more freely along axonal paths (longitudinally) and is more restricted across axons (perpendicularly), hindered by axonal and myelin membranes. Thus, diffusion properties are correlated with the brain’s microstructural development (e.g. myelination and axonal integrity) and altered in the presence of brain injury due to the breakdown of organelles/membranes19. Diffusion tensor tractography is a 3-dimensional rendering of dMRI that is produced by connecting voxels that exhibit the same local diffusion direction (i.e. fiber orientation), thereby inferring the presence of long-range white matter pathways/tracts in vivo20. This tool has highlighted the role various white matter tracts play in the pathophysiology of CP21. For example, in children with established CP, injury is observed not only in the corticospinal tract (CST), but also in other sensorimotor tracts such as the posterior subregions of the corpus callosum (CC) and posterior thalamic radiations (PTR)22,23. A systematic review of dMRI in children with CP further highlighted the involvement of additional sensorimotor tracts such as the superior thalamic radiations (STR) in the pathophysiology of CP24. It is not known if microstructural abnormalities of all sensorimotor tracts can be reliably measured soon after birth in those with CP and if so, can function as prognostic biomarkers of CP development in high-risk infants. We hypothesized that reduced structural connectivity of various sensorimotor tracts can be observed at term corrected age in extremely low birth weight infants (ELBW; ≤1000g) and this reduced connectivity can be modeled to accurately predict later development of CP.

2. Methods

2.1. Study design

For this prospective pilot cohort study, 50 consecutive ELBW infants were recruited from the neonatal intensive care unit of Children’s Memorial Hermann Hospital prior to hospital discharge. The inclusion criteria for study infants were infants cared for in the neonatal intensive care unit with a birth weight of 1000 g or less and survival to 34 weeks postmenstrual age or greater. Infants were excluded if they had known congenital CNS anomalies. Dates of enrollment were May 2007 to July 2009. Per clinical protocol, a brain sMRI was performed in all hospitalized ELBW infants prior to hospital discharge or at term corrected age and those with study consent also underwent dMRI. Standardized developmental testing was performed at 18 to 22 months corrected age.

2.2. Standard protocol approvals, registrations, and patient consents

The institutional review board of Children’s Memorial Hermann Hospital approved the study. Written informed consent was obtained from every parent/guardian of patients after the nature and possible consequences of the study were explained. All methods were carried out in accordance with the approved protocol and institutional guidelines.

2.3. Image acquisition

We performed all MRI scans on a 3T Philips Achieva scanner, equipped with a 32-channel receiver and a gradient system capable of producing gradient amplitudes of 80mT/m with a slew rate of 200 T/m/s. An 8-channel phased array head coil was used for data acquisition. The dMRI protocol consisted of a single-shot, spin-echo planar sequence with TR/TE, 6000/61; in plane resolution 1.6×1.6mm2, 2-mm contiguous slices, field of view 180 mm2, and 128×128 matrix; acquisition time 4 min. Fifteen directions of diffusion gradients were used with a b value of 800 s/mm2; SENSE factor = 2. The imaging parameters for the proton-density/T2-weighted scan were: TE1/TE2, 9/175; TR, 10,000; flip angle = 90°; field of view 180 mm2; 256×256 mm2 matrix; 2-mm contiguous slices; time 2:20 m. Total scan time was approximately 30 minutes.

We imaged all infants during natural sleep without the use of any sedation. Infants were fed and swaddled prior to MRI using a MedVac Infant Vacuum Splint (CFI Medical Solutions, Fenton, MI) and noise protection using Insta-Puffy Silicone Earplugs (E.A.R. Inc, Boulder, CO) and Natus Mini Muffs (Natus Medical Inc, San Carlos, CA). A single MR technologist performed all the scans; an experienced neonatologist and a neonatal research nurse supervised all scans. None of the patients experienced any adverse events during or after the MRI testing.

2.4. Image pre-processing

We pre-processed all dMRI images using FSL 5.0 software of FMRIB Software Library (Analysis Group, FMRIB, Oxford, UK) and DTIStudio 3.0.2 of MRI Studio (Johns Hopkins University, Baltimore, MD) as previously described25. Briefly, after eddy current correction in FSL, we performed Automatic Image Registration (AIR) and automatic outlier slice rejection in DTI Studio. Five infants had to be excluded due to significant motion artifacts on dMRI. Next, in FSL, we performed, tensor estimation and generated scalar maps (fractional anisotropy [FA], mean diffusivity [MD], radial diffusivity [RD], and axial diffusivity [AD]). Last, we performed brain extraction and employed BEDPOSTX (Bayesian Estimation of Diffusion Parameters Obtained using Sampling Techniques) to run probabilistic tractography26. The number of samples of probabilistic tracking was set at the default of 5000, the curvature threshold was set at 0.18, and a loop check was performed. The subsidiary threshold was set at 0.0 and step length at 0.4.

2.5. Image post-processing

For the six sensorimotor tracts of interest (Fig. 1), we employed color-coded tensor and FA maps to generate seed masks for the two CC tracts and seed masks and waypoint masks for the other 4 sensory and motor tracts of interest. We have previously described and published our mask regions of interest for the CST27, and posterior midbody (PMB) and isthmus of the CC25. Figure 2 displays the masks we used for the remaining 3 tracts – PTR, motor component of the STR (STRm), and sensory component of the STR (STRs). At least 2 orientations were used to select each region of interest. The connectivity distributions were generated from every voxel in the seed masks and only those paths that went through the waypoint masks were retained. We imported each tract’s seed point and waypoint masks into FSL’s probabilistic tracking with crossing fibers (PROBTRACKX) tool to perform probabilistic tractography26. An exclusion mask was not required for any of the tracks except for the PTR. For the PTR, an exclusion mask was drawn on the axial slice superior to the CC, covering the frontal lobe and the motor cortex to remove possible projection fibers that may be captured due to the seed point location in the thalamus. Diffusion parameters (FA, MD, AD, and RD) were assessed for each tract. The individual performing the dMRI data (AH) was masked to all clinical information, sMRI readings, and CP diagnosis but, as would be expected, was able to visualize overt signs of brain injury on diffusion maps during region of interest placements. To ensure good intra-rater reliability, we segmented a different set of cases prior to these study cases to establish consistency in methodology. The rater independently segmented the STRs, STRm, CST, and PTR of a random sample of 15 cases twice (separated by one month) to determine reliability. The mean ICC of the FA and MD for these four tracts ranged from 0.97–0.99. The ICC for the PMB and isthmus ranged from 0.87–0.92, as previously published25.

Figure 1. Sensorimotor network tractography superimposed on T2-weighted images in a very preterm infant.

Figure 1.

Coronal (A), sagittal (B), and axial (C) views of the corticospinal tract (light blue), posterior thalamic radiations (orange), superior thalamic radiations – motor segment (dark blue), superior thalamic radiations – sensory segment (pink), posterior mid-body of the corpus callosum (CC; red), and isthmus of the CC (yellow).

Figure 2. Axial color maps and fractional anisotropy (FA) maps displaying location of seed masks (SM) and waypoint masks (WM).

Figure 2.

(A) Waypoint mask for the posterior thalamic radiations (PTR; seed mask placed in thalamus using coronal view); (B) Common seed mask for superior thalamic radiations – motor (STRm) and sensory (STRs); (C) Waypoint mask for STRm; and (D) Waypoint mask for STRs.

2.6. Structural MRI readings

In our institution, brain sMRI replaced ultrasound as the clinical standard of care for brain injury screening before discharge, at term corrected age. A pediatric neuroradiologist read all sMRI studies blinded to clinical data, diffusion MRI, and CP diagnosis. We used a data-driven standardized scoring system that was previously demonstrated as highly predictive of CP28. This study showed that infants with severe brain injury (diffuse cystic abnormalities, diffuse punctate white matter lesions, and/or severe ventriculomegaly) exhibited the highest accuracy for predicting CP. We used this pre-specified definition of severe brain injury on sMRI to assess its ability to predict CP. We refrained from using a different definition that includes moderate degrees of white matter injury because although it increases test sensitivity, it concurrently lowers the specificity and positive likelihood ratio.

2.7. Follow-up and developmental assessments

All EBLW infants underwent a comprehensive neurodevelopmental assessment at 18 to 22 months of age corrected for prematurity, as previously described29. Certified examiners, masked to dMRI results, performed a standardized neurologic exam and gross motor function was assessed using the Gross Motor Function Classification System30. We defined CP as abnormal tone or reflexes in at least one extremity and abnormal control of movement or posture that interferes with age-appropriate activity. Severity of CP was defined as per Kuban et al31.

2.8. Statistical analysis

We anticipated that it would not be possible to perform tractography for one or more sensorimotor tracts for infants with injury in those regions. This was indeed the case for one infant for delineation of the PMB, isthmus, left CST and left STRm. An additional infant had right sided injury where delineation of the right CST and right STRm was not possible. We also could not perform tractography of the bilateral STRs for these two and one additional infant. For such infants, we decided a priori to impute diffusion values that were 4 standard deviations (SD) above (for MD, AD, RD) or below (for FA) the mean for our cohort. This strategy is akin to imputing a Bayley score of 46 (>4 SD below mean) for cognitive or language outcomes at age 2 for infants that are too disabled for testing. Attempting to perform tractography in brain injured infants also confirmed which infants with qualitatively defined brain injury had injury specifically to sensorimotor tracts. We compared diffusion parameters between children with and without CP using Wilcoxon rank sum test. We observed a significant difference in the postmenstrual age at MRI scan between the CP and no CP groups (Table 1). Because at least FA and RD are known to change significantly with increasing GA, all microstructural variables were adjusted for postmenstrual age at MRI scan24. For sensorimotor tract microstructural variables that were significantly different between groups, we further dichotomized these continuous measures at 2 SD above (for MD, AD, RD) or below (for FA) the mean for the non-CP group to create new categorical biomarkers. We selected this pre-specified standard cutoff because there is a lack of normative data and established thresholds for these potential biomarkers. We tested the prognostic properties of combining STRs FA with CST RD or combining STRs FA with STRm AD by creating two new combination biomarkers that was scored as positive if at least one of the single biomarkers was positive (using the 2 SD cutoff above) and negative when both biomarkers were negative. For categorical biomarkers, we performed Fischer’s exact test and examined receiver operating characteristic curves to compare sensitivity, specificity, likelihood ratios (LRs), and area under the receiver operating characteristic curve (AUC). Two-sided P-values of less than 0.05 were considered to indicate statistical significance. All analyses were conducted in Stata 15.1 (STATA Corporation, Texas, USA).

Table 1.

Baseline demographic and clinical characteristics of extremely low birth weight infants with and without cerebral palsy (CP).

Clinical variables No CP (N=36) CP (N=5) P Value
Maternal age 26 (18, 38) 26 (21, 29) 0.576
Antenatal steroids given, N (%) 28 (77.8%) 1 (20.0%) 0.020
Gestational age at birth, weeks 25.5 (23.1, 30.1) 25.4 (23.0, 26.3) 0.510
Birth weight, grams 765 (468, 1000) 720 (600, 909) 0.647
Male, N (%) 22 (61.1%) 4 (80.0%) 0.636
5 min Apgar score ≤5, N (%) 11 (30.6%) 1 (20.0%) 1.000
Small for gestational age, N (%) 2 (5.6%) 0 0.594
Postnatal steroids, N (%) 8 (22.2%) 2 (40.0%) 0.580
Sepsis (culture positive), N (%) 10 (27.8%) 2 (40.0%) 0.620
Positive pressure ventilation duration prior to 36 weeks postmenstrual age, days 49 (3, 88) 67 (39, 90) 0.157
Postmenstrual age at MRI scan, weeks 38.5 (34.1, 43.9) 43.1 (38.1, 43.7) 0.038

All values are median (range) unless otherwise noted.

3. Results

Of the original cohort of 50 ELBW infants, two infants died and two did not return for follow-up. An additional five infants were excluded due to significant motion artifacts on dMRI. Of the final cohort of 41 ELBW infants, five (12.2%) were diagnosed with CP at 18 to 22 months corrected age. The baseline characteristics of the cohort of infants that developed CP were similar to those that did not, except mothers of infants that developed CP received antenatal steroids less frequently and infants with CP had a significantly higher median age at MRI scan (Table 1). These same baseline characteristics of infants in the final cohort (N=41) were not significantly different than those not included in the study cohort (N=9). The sMRI findings and severity of CP for the 5 ELBW infants diagnosed with CP are presented in Table 2. Two infants without severe abnormalities on sMRI also developed CP (false negatives) and one diagnosed with severe abnormality (left-sided moderate ventriculomegaly and cystic periventricular leukomalacia [PVL]) did not develop CP (false positive). Overall, severe injury on sMRI exhibited 60.0% sensitivity and 97.1% specificity in predicting CP (p=0.004).

Table 2.

Baseline characteristics, structural MRI (sMRI) findings at term corrected age, and cerebral palsy (CP) severity of the five extremely low birth weight infants diagnosed with CP.

Subject Gestational Age (wks) Birth Weight (g) Sex Severe sMRI Abnormality sMRI Findings Cerebral Palsy Severity
1 23.0 720 Boy Yes Right encephalomalacia, S/P PVHI Hemiparesis
2 25.4 468 Boy No No injury or abnormalities Diaparesis
3 26.0 909 Boy Yes Bilateral encephalomalacia and ventriculomegaly, S/P PVHI Quadraparesis
4 26.3 600 Girl Yes Diffuse multicystic PVL Hemiparesis
5 23.6 665 Boy No Focal left-sided cyst Quadraparesis

All six segmented sensorimotor tracts are displayed in Fig. 1. We found significant differences in multiple diffusion microstructural parameters from these tracts in infants that developed CP versus those that did not (Table 3). As expected, the CST and STRm were the most closely associated with development of CP. However, we also identified significant differences in the STRs and the motor subregions of the CC (posterior midbody and isthmus). We did not observe any significant group differences in diffusion parameters from the PTR.

Table 3.

Sensorimotor tract diffusion parameters that were significantly different between five extremely low birth weight infants diagnosed with CP and 36 without CP.

Sensorimotor tract No CP
(N=36)*
CP
(N=5)*
P ValueΨ
Posterior midbody
FA 0.18 (.028) 0.12 (.024) 0.006
Isthmus
FA 0.19 (.005) 0.13 (.025) 0.027
STR - sensory
FA (B) 0.18 (.004) 0.14 (.025) 0.039
MD (B) 1.33 (.033) 1.64 (.016) 0.015
MD (L) 1.36 (.021) 1.75 (.191) 0.031
AD (L) 1.59 (.021) 1.97 (.181) 0.023
AD (B) 1.56 (.037) 1.87 (.151) 0.017
RD (L) 1.24 (.022) 1.76 (.267) 0.037
RD (B) 1.20 (.031) 1.62 (.221) 0.018
STR - motoe§
MD (L) 1.33 (.016) 1.48 (.058) 0.017
MD (B) 1.32 (.013) 1.47 (.070) 0.020
AD (L) 1.58 (.017) 1.73 (.045) 0.008
AD (B) 1.57 (.012) 1.72 (.055) 0.011
Corticospinal tract§
FA (R) 0.23 (.005) 0.14 (.042) 0.019
RD (R) 1.13 (.017) 1.41 (.159) 0.028
*

Mean (SE); All MD, AD, and RD values should be multiplied by 10−3

Ψ

P value determined using Wilcoxon rank sum test.

§

dMRI data not available for one baby from No CP group due to localized motion artifacts.

Abbreviations: STR – superior thalamic radiations; FA – fractional anisotropy; MD – mean diffusivity; AD – axial diffusivity; RD – radial diffusivity; L – left; R – right; B – bilateral

Three individual sensorimotor tract biomarkers – STRs FA, CST RD, and STRm AD – exhibited low sensitivity (40%–60%) but high specificity (97%–100%) in predicting CP (Table 4; Fig. 2). An abnormal STRs FA exhibited 100% specificity for development of CP. Both CST RD and STRm AD categorical biomarkers classified CP and non-CP cases similarly. Combining STRs FA with CST RD (or STRm AD) achieved the best sensitivity, negative LR and AUC of 80.0%, 0.21 and 0.886, respectively (Table 4). The combination of STRs FA and CST RD biomarkers correctly classified 95% of the ELBW infants (one false negative and one false positive).

Table 4.

Prognostic test properties for prominent diffusion MRI sensorimotor biomarkers.

Biomarker Threshold AUC
(95% CI)
Sensitivity
(95% CI)
Specificity
(95% CI)
Positive LR
(95% CI)
Negative LR
(95% CI)
P
STRs FA 0.1383 0.800
(0.560, 1.000)
60.0%
(14.7%, 95.7%)
100.0%
(90.3%, 100.0%)
0.40
(0.14, 1.17)
<0.001
CST RD 0.00135 0.686
(0.444, 0.927)
40.0%
(5.3%, 85.3%)
97.1%
(85.1%, 99.9%)
14.0
(1.54, 127.6)
0.62
(0.30, 1.27)
0.036
STRm AD 0.00172 0.686
(0.444, 0.927)
40.0%
(5.3%, 85.3%)
97.1%
(85.1%, 99.9%)
14.0
(1.54, 127.6)
0.62
(0.30, 1.27)
0.036
Combined* see above 0.886
(0.688, 1.000)
80.0%
(28.4%, 99.5%)
97.1%
(85.1%, 99.9%)
28.0
(3.9, 203.0)
0.21
(0.04, 1.19)
<0.001
*

Combination of STRs FA and CST RD biomarkers or STRs FA and STRm AD biomarkers

STRs – superior thalamic radiations, sensory; FA – fractional anisotropy; CST – corticospinal tract; RD – radial diffusivity; STRm – superior thalamic radiations, motor; AD – axial diffusivity; AUC – area under receiver operating characteristic curve; LR – likelihood ratio

4. Discussion

We identified several dMRI sensorimotor parameters that were significantly different in ELBW infants that later developed CP, suggesting the importance of a variety of sensorimotor tracts in the etiology and pathophysiology of CP. Moreover, three of these microstructural biomarkers were highly specific in diagnosing CP and additionally demonstrated enhanced sensitivity for prediction of CP when combined. For example, a combination of two of these biomarkers correctly classified 95% of the ELBW infants. The individual risk of developing CP for an ELBW infant with a baseline risk of 12.2% (prevalence of CP in this cohort used as prior probability) is 80% (posterior probability) for a positive biomarker combination test and 3% for a negative test32. The key limitation of our prognostications however was that we only had 5 cases of CP and therefore our 95% confidence limits for these prognostic properties were quite wide.

The combination of FA from the STRs and RD from the CST yielded the most accurate prediction of CP. Further, the combination of FA from the sensory and AD from the motor component of the STR yielded identical prediction of CP. Using either combination biomarker approach, we demonstrated higher sensitivity and positive LR to enhance identification of CP over sMRI when one or both biomarkers is positive and low negative LR to largely rule out diagnosis of CP when both biomarkers are negative. Our prognostic values are difficult to compare to prior published dMRI studies since most have not reported prognostic test properties18. However, they readily outperform sMRI prediction of CP as demonstrated in a recent meta-analysis of all eligible sMRI studies up to 2013 in very preterm infants and a 2015 published larger (N=445) multicenter study in ELBW infants7,15. The presence of moderate/severe white matter abnormalities in the meta-analysis exhibited a positive LR of 8.1 and negative LR of 0.3615 while the multicenter study reported a lower positive LR of 2.8 and negative LR of 0.62 (sensitivity, 48%; specificity, 83%) for prediction of CP7. For a given very preterm infant with moderate/severe WMA sMRI, a positive LR of 8.1 translates to a posterior probability of 37% for developing CP (using the meta-analysis CP pre-test probability/prevalence of 6.7%)32. These data suggest an unmet research and possible clinical need for additional prognostic biomarkers that could be met with dMRI biomarkers.

There has been strong interest and an emerging consensus to diagnose CP early, within a few months after birth in high-risk populations9,10. Such progress would mean that Early Intervention therapies could be targeted far earlier for the highest risk infants than is currently possible or the highest risk infants can be selected for neuroprotective trials. A prior systematic review of GMA and Hammersmith Infant Neurological Examination (HINE) studies at 3 months corrected age for CP prediction reported summary estimates of sensitivity, specificity, and positive LR for GMA of 98%, 91%, 10.9, respectively and for HINE of 88%, 87%, 6.8, respectively33. However, a large pragmatic study since that time suggests a much lower accuracy for the GMA during the fidgety period16. This multicenter study of GMA use in routine clinical practice, reported a much lower sensitivity of 56% and specificity of 87% (LR+ 4.3; LR– 0.50). Furthermore, current evidence suggests that combining sMRI with GMA does not increase sensitivity or accuracy in predicting CP34, possibly because these two tests are significantly correlated35. Even if sMRI was readily available in all centers, this suggests that individual level accurate prediction of CP is not yet possible with such tests. If our results can be validated in an independent large prospective study, as we are currently doing36, dMRI sensorimotor tract biomarkers could facilitate early, accurate risk stratification for CP by term corrected age, which would represent a significant advance for testing neuroprotective interventions.

Of the 6 sensorimotor tracts examined, we identified significant differences in infants with and without CP in all but one tract (PTR). While injury or immaturity of the CST is well-established in the etiology and pathophysiology of CP, our findings also highlight the importance of the sensory and motor components of the STR and subregions of the CC. Widespread sensorimotor abnormalities in FA, AD, and/or RD suggest injury and/or immaturity of white matter myelination and axonal integrity. Our findings are consistent with other dMRI studies performed at term corrected age identified in a recent systematic review of advanced MRI to predict neurodevelopmental outcomes in very preterm infants18. This review identified 3 tractography studies that reported microstructural connectivity parameters from either the posterior limb of the internal capsule (part of the CST)37,38 or CC39 were predictive of motor outcomes at 2 years corrected age. Other dMRI studies that did not perform tractography but queried regions of interest (2-dimensional) also reported significant associations between FA or MD in sensorimotor regions such as the posterior limb of the internal capsule4045, CC subregions4345, or basal nuclei46, and development of CP or abnormal gross motor scores. A 2013 systematic review of diffusion MRI studies also highlighted the aberrant development and involvement of several sensorimotor tracts other than the CST in older children with established CP24. While these dMRI studies examined and identified the involvement of one or two regions or biomarkers, comprehensive study of most of the major sensorimotor tracts permitted us to uncover significant differences in 5 such tracts in very preterm infants with CP. Additionally, examination of prognostic test properties permitted determination of the clinical value of such biomarkers for individualized prognostication. Our study verifies the findings of this systematic review that CP results from brain injury or immaturity of structural connectivity in one or more regions of the sensorimotor network. Importantly, we also extended this data by identifying these abnormalities in preterm infants soon after birth and combining biomarkers to improve CP prediction accuracy.

Similar to the systematic review findings from Schenk et al.24 in older children with CP, we observed that CP is preceded by the presence of microstructural injury/immaturity soon after birth in one or more sensorimotor tracts. Additionally, our findings of abnormal FA, AD and/or RD in these tracts suggest that the type of injury/immaturity may also be heterogeneous. Overall, an increase in radial (perpendicular) diffusivity suggests underlying demyelination or delayed myelination, while aberrant axial (parallel) diffusivity is closely associated with axonal injury/immaturity or necrosis and decrease in FA is typically observed when one or both of these pathological processes are present47. When examined histopathologically, this heterogeneous CP injury phenotype, results in a range of pathological outcomes, including focal necrosis with loss of cellular elements, including axons, and diffuse non-necrotic injury characterized by arrested pre-oligodendrocytes maturation with resulting delays in myelination48,49. The five infants with CP in our study exhibited a similar range of macrostructural injuries (Table 2) with resulting microstructural changes, as shown on dMRI and sensorimotor tract biomarkers. Depending on the underlying types of CP represented in the cohort, another study may yield somewhat different results. Therefore, a much larger cohort study that is representative of the most common CP phenotypes will provide the most robust assessment of the ultimate value of sensorimotor tract prognostic biomarkers.

Our study has several limitations. Studies using small sample sizes are more prone to prognostic over-optimism, as reflected in our wide confidence intervals, and therefore independent validation in a larger cohort will be required. We only used 15 diffusion directions and a single shell, which limited our ability to fully exploit the power of this technology. We are addressing these limitations in our current ongoing study. The addition of brain morphometric biomarkers such as brain volumes and cortical surface measures may further enhance our ability to predict motor outcomes18. Because the focus of our study was prediction of CP, we limited our analyses to sensorimotor tracts; however, it is also important to examine additional white matter tracts that subserve additional important functions that are known to be abnormal in some children with CP (e.g., cognitive, visual). We and others have previously published region of interest-based analyses of these tracts and shown significant correlations with cognitive and language scores43,50. Current availability of neonatal structural atlases is making it easier to perform whole brain structural connectivity, which may replace manual parcellation methods. We are currently conducting a large prospective, population-based cohort study designed to address these limitations and to externally validate our promising findings36.

5. Conclusions

Development of CP in very preterm infants is preceded by early brain injury/immaturity to one or more sensorimotor tracts that can be identified as early as term corrected age using diffusion tractography. In this single-center pilot cohort study, combined microstructural parameters from these tracts predicted later diagnosis of CP with good accuracy. Larger population-based, structural and functional connectivity studies are needed to determine the value of sensorimotor connectivity parameters as robust prognostic biomarkers for early, accurate diagnosis of cerebral palsy.

Acknowledgements.

This work was supported by National Institutes of Health grants UL1 RR024148–04S3 (National Center for Research Resources/Eunice Shriver National Institute of Child Health & Human Development grant), R01-NS096037 and R01-NS094200 (both from the National Institutes of Neurological Diseases and Stroke). The funding sources were not involved in the study design, data analysis/interpretation, writing of the manuscript, or in the decision to submit the article for publication. We thank all study families for participating in this study and Katrina Burson, BSN, MS for recruiting study infants.

Abbreviations:

AD

axial diffusivity

CC

corpus callosum

CP

cerebral palsy

CST

corticospinal tract

dMRI

diffusion magnetic resonance imaging

ELBW

extremely low birth weight infant

FA

fractional anisotropy

GMA

general movements assessment

HINE

Hammersmith infant neurological exam

LR

likelihood ratio

MD

mean diffusivity

PTR

posterior thalamic radiations

RD

radial diffusivity

sMRI

qualitative structural magnetic resonance imaging

STRm

superior thalamic radiations, motor

STRs

superior thalamic radiations, sensory

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Competing interests. The authors declare no competing interests.

Data availability statement. All of the data generated or analyzed during this study are included in this published article. They are also available from the corresponding author on reasonable request.

References

  • 1.Ashwal S, Russman BS, Blasco PA, et al. Practice parameter: diagnostic assessment of the child with cerebral palsy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology. 2004;62(6):851–863. [DOI] [PubMed] [Google Scholar]
  • 2.Himmelmann K Epidemiology of cerebral palsy. Handb Clin Neurol. 2013;111:163–167. [DOI] [PubMed] [Google Scholar]
  • 3.Hubermann L, Boychuck Z, Shevell M, Majnemer A. Age at Referral of Children for Initial Diagnosis of Cerebral Palsy and Rehabilitation: Current Practices. J Child Neurol. 2016;31(3):364–369. [DOI] [PubMed] [Google Scholar]
  • 4.Bax M, Tydeman C, Flodmark O. Clinical and MRI correlates of cerebral palsy: the European Cerebral Palsy Study. JAMA. 2006;296(13):1602–1608. [DOI] [PubMed] [Google Scholar]
  • 5.Hadders-Algra M Early diagnosis and early intervention in cerebral palsy. Front Neurol. 2014;5:185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Benini R, Dagenais L, Shevell MI, Registre de la Paralysie Cerebrale au Quebec C. Normal imaging in patients with cerebral palsy: what does it tell us? J Pediatr. 2013;162(2):369–374 e361. [DOI] [PubMed] [Google Scholar]
  • 7.Hintz SR, Barnes PD, Bulas D, et al. Neuroimaging and neurodevelopmental outcome in extremely preterm infants. Pediatrics. 2015;135(1):e32–42. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.de Vries LS, van Haastert IC, Benders MJ, Groenendaal F. Myth: cerebral palsy cannot be predicted by neonatal brain imaging. Semin Fetal Neonatal Med. 2011;16(5):279–287. [DOI] [PubMed] [Google Scholar]
  • 9.Herskind A, Greisen G, Nielsen JB. Early identification and intervention in cerebral palsy. Dev Med Child Neurol. 2015;57(1):29–36. [DOI] [PubMed] [Google Scholar]
  • 10.Novak I, Morgan C, Adde L, et al. Early, Accurate Diagnosis and Early Intervention in Cerebral Palsy: Advances in Diagnosis and Treatment. JAMA Pediatr. 2017;171(9):897–907. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Brooks-Gunn J, McCarton CM, Casey PH, et al. Early intervention in low-birth-weight premature infants. Results through age 5 years from the Infant Health and Development Program. JAMA. 1994;272(16):1257–1262. [PubMed] [Google Scholar]
  • 12.Damiano DL. Activity, activity, activity: rethinking our physical therapy approach to cerebral palsy. Phys Ther. 2006;86(11):1534–1540. [DOI] [PubMed] [Google Scholar]
  • 13.Spittle A, Orton J, Anderson P, Boyd R, Doyle LW. Early developmental intervention programmes post-hospital discharge to prevent motor and cognitive impairments in preterm infants. Cochrane Database Syst Rev. 2012;12:CD005495. [DOI] [PubMed] [Google Scholar]
  • 14.Shepherd R Cerebral Palsy in Infancy: Targeted Activity to Optimize Early Growth and Development. 1st ed: Elsevier Ltd.; 2013. [Google Scholar]
  • 15.Van’t Hooft J, van der Lee JH, Opmeer BC, et al. Predicting developmental outcomes in premature infants by term equivalent MRI: systematic review and meta-analysis. Syst Rev. 2015;4:71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Datta AN, Furrer MA, Bernhardt I, et al. Fidgety movements in infants born very preterm: predictive value for cerebral palsy in a clinical multicentre setting. Dev Med Child Neurol. 2017;59(6):618–624. [DOI] [PubMed] [Google Scholar]
  • 17.Parikh NA. Are Structural Magnetic Resonance Imaging and General Movements Assessment Sufficient for Early, Accurate Diagnosis of Cerebral Palsy? JAMA Pediatr. 2018;172(2):198–199. [DOI] [PubMed] [Google Scholar]
  • 18.Parikh NA. Advanced neuroimaging and its role in predicting neurodevelopmental outcomes in very preterm infants. Semin Perinatol. 2016;40(8):530–541. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Le Bihan D Apparent diffusion coefficient and beyond: what diffusion MR imaging can tell us about tissue structure. Radiology. 2013;268(2):318–322. [DOI] [PubMed] [Google Scholar]
  • 20.Jeurissen B, Descoteaux M, Mori S, Leemans A. Diffusion MRI fiber tractography of the brain. NMR Biomed. 2017. [DOI] [PubMed] [Google Scholar]
  • 21.Ceschin R, Lee VK, Schmithorst V, Panigrahy A. Regional vulnerability of longitudinal cortical association connectivity: Associated with structural network topology alterations in preterm children with cerebral palsy. Neuroimage Clin. 2015;9:322–337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Hoon AH Jr., Lawrie WT Jr., Melhem ER, et al. Diffusion tensor imaging of periventricular leukomalacia shows affected sensory cortex white matter pathways. Neurology. 2002;59(5):752–756. [DOI] [PubMed] [Google Scholar]
  • 23.Hoon AH Jr., Stashinko EE, Nagae LM, et al. Sensory and motor deficits in children with cerebral palsy born preterm correlate with diffusion tensor imaging abnormalities in thalamocortical pathways. Dev Med Child Neurol. 2009;51(9):697–704. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Scheck SM, Boyd RN, Rose SE. New insights into the pathology of white matter tracts in cerebral palsy from diffusion magnetic resonance imaging: a systematic review. Dev Med Child Neurol. 2012;54(8):684–696. [DOI] [PubMed] [Google Scholar]
  • 25.Teli R, Hay M, Hershey A, Kumar M, Yin H, Parikh NA. Postnatal Microstructural Developmental Trajectory of Corpus Callosum Subregions and Relationship to Clinical Factors in Very Preterm Infants. In press. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Behrens TE, Berg HJ, Jbabdi S, Rushworth MF, Woolrich MW. Probabilistic diffusion tractography with multiple fibre orientations: What can we gain? Neuroimage. 2007;34(1):144–155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Kaur S, Powell S, He L, Pierson CR, Parikh NA. Reliability and repeatability of quantitative tractography methods for mapping structural white matter connectivity in preterm and term infants at term-equivalent age. PLoS One. 2014;9(1):e85807. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Slaughter LA, Bonfante-Mejia E, Hintz SR, Dvorchik I, Parikh NA. Early Conventional MRI for Prediction of Neurodevelopmental Impairment in Extremely-Low-Birth-Weight Infants. Neonatology. 2016;110(1):47–54. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Vaucher YE, Peralta-Carcelen M, Finer NN, et al. Neurodevelopmental outcomes in the early CPAP and pulse oximetry trial. N Engl J Med. 2012;367(26):2495–2504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Amiel-Tison C, Gosselin J. Neurological Development from Birth to Six Years. Balitmore, MD: The John Hopkins University Press; 1998. [Google Scholar]
  • 31.Kuban KC, Allred EN, O’Shea M, et al. An algorithm for identifying and classifying cerebral palsy in young children. J Pediatr. 2008;153(4):466–472. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Diagnostic Test Calculator for calculation of posterior probability. http://araw.mede.uic.edu/cgi-bin/testcalc.pl. Accessed March 21, 2018.
  • 33.Bosanquet M, Copeland L, Ware R, Boyd R. A systematic review of tests to predict cerebral palsy in young children. Developmental Medicine & Child Neurology. 2013;55(5):418–426. [DOI] [PubMed] [Google Scholar]
  • 34.Constantinou JC, Adamson-Macedo EN, Mirmiran M, Fleisher BE. Movement, imaging and neurobehavioral assessment as predictors of cerebral palsy in preterm infants. J Perinatol. 2007;27(4):225–229. [DOI] [PubMed] [Google Scholar]
  • 35.Olsen JE, Brown NC, Eeles AL, et al. Early general movements and brain magnetic resonance imaging at term-equivalent age in infants born <30weeks’ gestation. Early Hum Dev. 2016;101:63–68. [DOI] [PubMed] [Google Scholar]
  • 36.[Internet] Cg. The Early Prediction Study (EPS) In: (US) NLoM, ed. Bethesda, MD: 2017. November 15 [cited 2017 November 15}; 2000, Feb 29 −. [Google Scholar]
  • 37.van Kooij BJ, van Pul C, Benders MJ, van Haastert IC, de Vries LS, Groenendaal F. Fiber tracking at term displays gender differences regarding cognitive and motor outcome at 2 years of age in preterm infants. Pediatr Res. 2011;70(6):626–632. [DOI] [PubMed] [Google Scholar]
  • 38.de Bruine FT, Van Wezel-Meijler G, Leijser LM, et al. Tractography of white-matter tracts in very preterm infants: a 2-year follow-up study. Dev Med Child Neurol. 2013;55(5):427–433. [DOI] [PubMed] [Google Scholar]
  • 39.Thompson DK, Inder TE, Faggian N, et al. Corpus callosum alterations in very preterm infants: perinatal correlates and 2 year neurodevelopmental outcomes. Neuroimage. 2012;59(4):3571–3581. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Arzoumanian Y, Mirmiran M, Barnes PD, et al. Diffusion Tensor Brain Imaging Findings At Term-equivalent Age May Predict Neurologic Abnormalities in Low Birth Weight Preterm Infants. American Journal of Neuroradiology. 2003;24(8):1646–1653. [PMC free article] [PubMed] [Google Scholar]
  • 41.Drobyshevsky A, Bregman J, Storey P, et al. Serial diffusion tensor imaging detects white matter changes that correlate with motor outcome in premature infants. Dev Neurosci. 2007;29(4–5):289–301. [DOI] [PubMed] [Google Scholar]
  • 42.Rose J, Mirmiran M, Butler EE, et al. Neonatal microstructural development of the internal capsule on diffusion tensor imaging correlates with severity of gait and motor deficits. Dev Med Child Neurol. 2007;49(10):745–750. [DOI] [PubMed] [Google Scholar]
  • 43.Duerden EG, Foong J, Chau V, et al. Tract-Based Spatial Statistics in Preterm-Born Neonates Predicts Cognitive and Motor Outcomes at 18 Months. AJNR Am J Neuroradiol. 2015;36(8):1565–1571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Rose J, Cahill-Rowley K, Vassar R, et al. Neonatal brain microstructure correlates of neurodevelopment and gait in preterm children 18–22 mo of age: an MRI and DTI study. Pediatr Res. 2015;78(6):700–708. [DOI] [PubMed] [Google Scholar]
  • 45.Malavolti AM, Chau V, Brown-Lum M, et al. Association between corpus callosum development on magnetic resonance imaging and diffusion tensor imaging, and neurodevelopmental outcome in neonates born very preterm. Dev Med Child Neurol. 2017;59(4):433–440. [DOI] [PubMed] [Google Scholar]
  • 46.Chau V, Synnes A, Grunau RE, Poskitt KJ, Brant R, Miller SP. Abnormal brain maturation in preterm neonates associated with adverse developmental outcomes. Neurology. 2013;81(24):2082–2089. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Winklewski PJ, Sabisz A, Naumczyk P, Jodzio K, Szurowska E, Szarmach A. Understanding the Physiopathology Behind Axial and Radial Diffusivity Changes-What Do We Know? Front Neurol. 2018;9:92. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Folkerth RD. Neuropathologic substrate of cerebral palsy. J Child Neurol. 2005;20(12):940–949. [DOI] [PubMed] [Google Scholar]
  • 49.Buser JR, Maire J, Riddle A, et al. Arrested preoligodendrocyte maturation contributes to myelination failure in premature infants. Ann Neurol. 2012;71(1):93–109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Pogribna U, Yu X, Burson K, et al. Perinatal clinical antecedents of white matter microstructural abnormalities on diffusion tensor imaging in extremely preterm infants. PLoS One. 2013;8(8):e72974. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES